Ledger.Open graph →

SEC Form D · filed May 14, 2019

EFFECTOR THERAPEUTICS, INC

Offering

$21.8M

Sold

$20.4M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN DIEGO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Stephen T. Worland, Ph.D · San Diego, CAExec · Director Alana T. Mcnulty · San Diego, CAExec David D. Maki, J.D · San Diego, CADirector Jonathan D. Root, M.D · San Diego, CADirector Kenneth J. Haas, J.D · San Diego, CADirector Simeon J. George, M.D · San Diego, CADirector Laurence T. Lasky, Ph.D · San Diego, CADirector John L. Quinn · St. Louis, MODirector S. C. Honig · San Mateo, CADirector Stevan Rosenberg · Farmington Hills, MIExec · Director Judith O'Brien · Boulder, CODirector Mark Brown · Lubbock, TXDirector Kriss E. Spradley · CHICAGO, ILExec Michael L. Bavely · St. Louis, MODirector Denis W. Patrick, Ph.D · San Diego, CADirector John W. Smither · San Diego, CADirector Stefan D. Larson, Ph.D · San Diego, CADirector Henry C. Hansel · CHICAGO, ILExec · Director Raymond T. Kish · CHICAGO, ILExec Mark L. Olson · WALNUT CREEK, CADirector Susan R. Molina · WALNUT CREEK, CADirector Lori Greymont · Morgan Hill, CADirector Rohit Syal · Chicago, ILDirector Michael L. Pistner · Washington, Washington, D.C.Director Denis W. Patrick, Ph.D · San Diego, CADirector John W. Smither · San Diego, CADirector Stefan D. Larson, Ph.D · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗